Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a fixed-dose combination of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients with advanced liver disease or post-li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Disease
• Liver Transplant Status

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic HCV Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-06-20